0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

The Ongoing Debate of Who to Treat for Chronic Hepatitis C Virus

Marc G. Ghany, MD, MHSc1
[+] Author Affiliations
1Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
JAMA Intern Med. 2015;175(2):169-170. doi:10.1001/jamainternmed.2014.4299.
Text Size: A A A
Published online

Extract

Chronic hepatitis C virus (HCV) infection accounts for approximately 30% of cases of cirrhosis and one-quarter of hepatocellular carcinomas worldwide and is the leading indication for liver transplant in the adult US population.1 Although the incidence of chronic HCV infection is declining in the United States, the number of deaths is projected to rise over the next decade because of complications among persons infected 30 to 40 years ago.2 Hence, the major reasons for treating chronic HCV infection are to mitigate the morbidity and mortality associated with the infection, alleviate patient symptoms, and prevent person-to-person transmission. Successful eradication or virological cure is possible, and a reduction in liver-related outcomes has been demonstrated in patients with advanced liver disease who achieve this desirable end point.3

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

2,019 Views
4 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Care at the Close of Life: Evidence and Experience
Viral Hepatitis and ESLD

brightcove.createExperiences();